4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Myeloproliferative Disorders in 1 studies
WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, T | 1 |
| Toki, T | 1 |
| Kanezaki, R | 1 |
| Xu, G | 1 |
| Terui, K | 1 |
| Kanegane, H | 1 |
| Miura, M | 1 |
| Adachi, S | 1 |
| Migita, M | 1 |
| Morinaga, S | 1 |
| Nakano, T | 1 |
| Endo, M | 1 |
| Kojima, S | 1 |
| Kiyoi, H | 1 |
| Mano, H | 1 |
| Ito, E | 1 |
1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Myeloproliferative Disorders
| Article | Year |
|---|---|
Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome.
Topics: Base Sequence; Cell Proliferation; Dose-Response Relationship, Drug; Down Syndrome; Female; Humans; | 2008 |